Sonnet BioTherapeutics Holdings, Inc. Profile Avatar - Palmy Investing

Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human sin…

Biotechnology
US, Princeton [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of SONN's Analysis
CIK: 1106838 CUSIP: 83548R105 ISIN: US83548R3030 LEI: - UEI: -
Secondary Listings
SONN has no secondary listings inside our databases.